ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2715

Incidence of Juvenile Idiopathic Arthritis in the United Kingdom: Estimates from a National Primary Care Dataset

Ruth Costello1, Janet McDonagh 2, Will Dixon 1, Kimme Hyrich 2 and Jenny Humphreys 1, 1Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom, Manchester, United Kingdom, 2Versus Arthritis Centre for Epidemiology, Centre for Musculoskeletal Research, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, United Kingdom / NIHR Manchester Biomedical Research Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, United Kingdom, Manchester, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Epidemiologic methods, juvenile idiopathic arthritis (JIA), Public Health Approach and juvenile arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Pediatric Rheumatology – ePoster III: Systemic JIA, Fever, & Vasculitis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Juvenile idiopathic arthritis (JIA) is the most common childhood onset inflammatory arthritis.  The last estimates of incidence of this disease in the United Kingdom are from nearly 30 years ago, prior to international classification consensus and the emergence of paediatric and adolescent rheumatology as a specialty.  The aim of this study was to estimate incidence of JIA from primary care records in the UK since 2000.

Methods: The study used data from the Clinical Practice Research Datalink (CPRD) Gold, a database of UK primary care records considered broadly representative of the UK as a whole in terms of age, gender and ethnicity.  A pre-defined list of JIA Read codes were used to identify incident cases annually from 2000-2018.  Incidence rates with 95% confidence intervals (CI) were calculated.  The denominator was the population of CPRD < 16 years old on the 31st December each year.  Age and gender stratified rates were calculated. Direct standardisation was used to estimate the UK IR using the Office for National Statistics mid-2017 population data (latest available). Incidence rates in 5-year groupings were calculated 2000-2015 to identify any change over time.

Results: There were 1927 incident cases of JIA from 2000-2018, from a total population of 23,328,676 children < 16 years old in CPRD.  This gave a total incident rate (IR) (95% confidence interval (CI)) of 8.26 (7.90-8.64) per 100,000 population.  There was a slight female preponderance, with IR (95% CI) 9.83 (9.27-10.43) per 100,000 in females, compared to 6.78 (6.33-7.27) per 100,000 in males.  Age adjusted direct standardisation to the UK population estimated a total IR of 9.66 per 100,000 person years.  Incident rates by age group are shown in table 1.  There appeared to be a slightly lower incidence in middle childhood compared to early childhood and adolescents, as well as infancy where lower rates may be due to difficulties in recognising the disease.   IRs over time did not appear to change (figure 1).

Conclusion: This is the first study to provide contemporary UK estimates of the incidence of JIA for nearly 30 years.  We have shown JIA is more common in girls compared to boys, and is slightly more common in early childhood and adolescence compared to other age groups.  Incidence appears to have been stable over a fifteen-year period.  These data provide important information for patients, their families and healthcare providers; in addition, they are vital for appropriate resource planning and service provision in paediatric and adolescent rheumatology.

Table 1 Incidence rates by age group

Figure 1 Incidence rates over time


Disclosure: R. Costello, None; J. McDonagh, None; W. Dixon, None; K. Hyrich, AbbVie, 2, 8, BMS, 2, Pfizer, 2, UCB, 2; J. Humphreys, None.

To cite this abstract in AMA style:

Costello R, McDonagh J, Dixon W, Hyrich K, Humphreys J. Incidence of Juvenile Idiopathic Arthritis in the United Kingdom: Estimates from a National Primary Care Dataset [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/incidence-of-juvenile-idiopathic-arthritis-in-the-united-kingdom-estimates-from-a-national-primary-care-dataset/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-of-juvenile-idiopathic-arthritis-in-the-united-kingdom-estimates-from-a-national-primary-care-dataset/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology